Financial Times|11月 11, 2026 04:34
The biotech group most famous for its Covid-19 jab believes its personalised cancer vaccine, which is expected to win US regulatory approval next year, could be bigger than the bestselling oncology drug ever
ft.trib.al/pNGqAcF(金融时报)
Share To
Timeline
HotFlash
APP
X
Telegram
CopyLink